Horan Capital Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-100
Closed -$4K 99
2020
Q3
$4K Buy
+100
New +$4.24K ﹤0.01% 278
2020
Q1
Sell
-100
Closed -$3K 84
2019
Q4
$3K Hold
100
﹤0.01% 250
2019
Q3
$2K Buy
+100
New +$2.85K ﹤0.01% 265
2019
Q2
Sell
-100
Closed -$3K 83
2019
Q1
$3K Buy
+100
New +$3.04K ﹤0.01% 240
2017
Q4
Sell
-100
Closed -$2K 79
2017
Q3
$2K Buy
+100
New +$2.26K ﹤0.01% 301

Other funds holding ATRC

Horan Capital Advisors's ATRC Position: Q4 2020 in Review

Horan Capital Advisors sold out of AtriCure (ATRC) in Q4 2020, closing a stake of 100 shares — an estimated $4K sold.

Horan Capital Advisors first reported a position in ATRC in Q3 2017 and held it in 5 quarters. The position peaked at $4K in Q3 2020. 198 funds tracked by Wall St. Rank hold ATRC as of Q4 2020.

  • Horan Capital Advisors reported no remaining AtriCure position as of Q4 2020 after selling out during the quarter.
  • Horan Capital Advisors sold 100 AtriCure shares in Q4 2020, an estimated $4K.
  • Horan Capital Advisors first reported a position in AtriCure in Q3 2017 and held it in 5 quarters.
  • Horan Capital Advisors's AtriCure position peaked at $4K in Q3 2020.
  • 198 funds tracked by Wall St. Rank held AtriCure as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.